Serial 97767006
Live / Applied — Ex parte appeal pending (as of 24 Oct 2025)
What this means for you
Not registered yet, but its 25 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97767006
- Mark type
- Design / logo
- Filed
- 25 Jan 2023
- Attorney of record
- TRINA A. LONGO
Goods and services
- Class 005 — Pharmaceuticals: Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers for medical use, sold filled with pharmaceutical preparations for the treatment of respiratory diseases and disorders
- Class 010 — Medical apparatus: Medical delivery system, apparatus, and instruments, namely, inhalers, sold empty, for the localized orally inhaled and systemic delivery of pharmaceutical preparations; Medical delivery system, apparatus, and instruments for facilitating the delivery of biological formulations, monoclonal antibodies, organic small molecule formulations, inorganic molecules formulations, peptides, proteins, oligonucleotides, RNA, DNA, vaccines, radiopharmaceuticals and nutraceuticals and combinations thereof; Medical delivery system, apparatus, and instruments, namely, inhalers for medical use, sold empty; Medical delivery system and apparatus for facilitating the inhalation of pharmaceutical preparations; Inhalers for medical use, sold empty; drug delivery devices sold empty, namely, inhalers
Owner
- Transpire Bio Inc, Weston, FL, US
Prosecution history
- 17 Oct 2025 — NOTIFICATION OF SUBSEQUENT FINAL EMAILED
- 17 Oct 2025 — SUBSEQUENT FINAL EMAILED
- 17 Oct 2025 — SUBSEQUENT FINAL REFUSAL WRITTEN
- 30 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 30 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 31 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION WRITTEN
- 28 Mar 2025 — USE AMENDMENT ACCEPTED
- 13 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Nov 2024 — AMENDMENT TO USE PROCESSING COMPLETE